openPR Logo
Press release

Bone Morphogenetic Proteins Market - Key Futuristic Trends And Competitive Landscape 2024

06-21-2017 03:43 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Bone Morphogenetic Proteins Market - Key Futuristic Trends

Bone morphogenetic proteins (BMPs) that are classified under transforming growth factor beta superfamily are multifactorial growth factors. These are naturally occurring proteins found in the human body, involved in numerous cellular responses. BMPs were first isolated in 1965 by scientist Marshall Urist for the ability to induce the formation of bone and cartilage. To date over 15 BMPs have been isolated and cloned. However, only BMP-2 and BMP-7 are considered to show the greatest amount of osteoinductive potential. Both the types of BMPs share similar kind of cell receptors (Type 1 and Type 2 BMP receptor) that help in regulating bone growth. Thus, for clinical use, BMPs are produced through recombinant DNA technology namely rhBMP-2 and rhBMP-7. These BMPs have been approved by the FDA for use in orthopedic applications such as spinal fusions, oral surgery, and tibia non-unions. These proteins posses the ability to induce patients own cells for bone formation. In addition, BMPs have proved to be beneficial for patients undergoing spinal fusion surgery by eliminating the need for bone harvesting from the pelvis region. This innovative research approach also reduces the amount of pain, dependence on spinal rods or screws, and augments the rate of spinal fusion. Although, BMPs have proved to be a noteworthy bone graft substitute in spinal fusion, a variety of complications are associated with its off-label usage. Uncontrolled bone formation, bone overgrowth, male sterility, leg pain, back pain, respiratory complication, and inflammation are some of the side effects associated with the implant of BMPs. Thus, the market for BMPs has been restricted by biocompatibility issues, high cost, strict regulations, and presence of numerous bone graft substitutes.

Read the Comprehensive Overview of Bone Morphogenetic Proteins Market: http://www.transparencymarketresearch.com/bone-morphogenetic-protein-market.html

The global bone morphogenetic proteins market is studied based on the types of recombinant BMPs, applications, and geography. Based on recombinant BMP types, the market has been further segmented into two major segments namely, rhBMP-2 and liquid rhBMP-7. Among the type segments, the rhBMP-2 segment accounted for the largest share (in terms of revenue) of the market in 2013. rhBMP-2 has been widely accepted by physicians and surgeons across the globe due to their effectiveness in treating lower back spinal fusions. rhBMP-7 on the other hand is expected to completely diminish from the market in the future due to withdrawal of OP-1/Opgenra from the market since August 2014. In terms of application, spinal fusion currently accounts for the largest share of the market, followed by trauma. However, the reconstructive segment is likely to grow at a low CAGR during the forecast period from 2014 to 2022. The reason for sluggish growth is limited usage of BMP products for reconstructive surgery and presence of numerous well-established alternative bone graft substitutes.

In terms of regional distribution, North America currently accounts for the largest share of the bone morphogenetic proteins market, followed by Europe. Furthermore, North America, with a market share of over 70%, is expected to dominate the industry during the forecast period. This leadership would be witnessed due to high awareness about BMP products, availability of premium priced recombinant BMP products, and soaring number of spinal fusion procedures. Furthermore, highest growth of this industry is expected to emerge in Asia Pacific during the forecast period. The global bone morphogenetic proteins market is characterized by three players namely Medtronic plc, Olympus Biotech, and Cellumed.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2308

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bone Morphogenetic Proteins Market - Key Futuristic Trends And Competitive Landscape 2024 here

News-ID: 590114 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for BMP

Bone Morphogenetic Protein (BMP) Market 2022 | Detailed Report
This report provides an informative view about the competitive aspect of the global market. It includes detailed picture of the exhibition of a portion of the essential global players working in the Bone Morphogenetic Protein (BMP) market. The research study also provides historical record with profits predictions and forecasts from 2022 to 2028. Also, the business manufacturing of the notable manufacturers is also emphasized with technical data in the report. This
Global Bone Morphogenetic Protein (BMP) 2 Sales Market Report 2018
In this report, the global Bone Morphogenetic Protein (BMP) 2 market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Free | Request Sample Copy of the Report @ https://bit.ly/2MbknYj Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of
Barcode Saving in BMP, SVG, GIF & TIFF Formats inside Cloud Apps
What's New in this Release? Aspose team is pleased to announce the new release of Aspose.BarCode for Cloud 18.3. This release provides support to save barcode in BMP, SVG, GIF and TIFF format, and released a fully reworked version of .NET, Node.js and PHP Cloud SDKs. There are some important new features included in this release, such as included support for saving barcode in BMP, saving barcode in SVG format
Databar Coded Barcode Generation & Enhanced Barcode Detection from BMP Images us …
What's New in this Release? Aspose team is pleased to announce the new version of Aspose.BarCode for Java 17.9.0. This release includes enhanced DatabarLimited and DatabarExpandedStacked coded barcode generation process. Furthermore overall performance of the API has also been improved in this release. DatabarLimited barcode generation process has been improved. The functionality has been improved in such a way that it now allows only (01) AI and 0 or 1
Bone Morphogenetic Protein (BMP) 2 Market 2017 - Stryker, Medtronic, Cellumed
Apex Research, recently published a detailed market research study focused on the "Bone Morphogenetic Protein (BMP) 2 Market" across the global, regional and country level. The report provides 360° analysis of "Bone Morphogenetic Protein (BMP) 2 Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Bone Morphogenetic Protein (BMP) 2 industry, and
bmp media investors: bmp invests in komoot GmbH
Berlin, 7 November 2013 - bmp media investors AG (ISIN DE0003304200) has acquired a 5.34% interest in komoot GmbH in a round of financing. Alongside bmp media investors, other investors include Mittelständische Beteiligungsgesellschaft Berlin-Brandenburg GmbH, Potsdam, and KRW Schindler Investments S.A., Luxembourg. komoot GmbH, based in Potsdam, offers an app of the same name for outdoor activities that allows users to plan and adapt bike rides and hiking expeditions in line